Johnson et al., 2014 - Google Patents
The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine‐expressing platelets and platelet microparticlesJohnson et al., 2014
- Document ID
- 1635335248222185896
- Author
- Johnson L
- Coorey C
- Marks D
- Publication year
- Publication venue
- Transfusion
External Links
Snippet
Background Cryopreservation of platelets (PLT s) at− 80° C with dimethyl sulfoxide (DMSO) can extend the shelf life from 5 days to 2 years. Cryopreserved PLT s are reported to have a greater in vivo hemostatic effect than liquid‐stored PLT s. As such, the aim of this study was …
- 210000001772 Blood Platelets 0 title abstract description 118
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Johnson et al. | The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine‐expressing platelets and platelet microparticles | |
Johnson et al. | In vitro comparison of cryopreserved and liquid platelets: potential clinical implications | |
Braathen et al. | In vitro quality and platelet function of cold and delayed cold storage of apheresis platelet concentrates in platelet additive solution for 21 days | |
Acker et al. | Quality assessment of established and emerging blood components for transfusion | |
Pidcoke et al. | Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time | |
Apelseth et al. | In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma‐irradiated single‐donor platelet concentrates during long‐term storage | |
Levin et al. | Implementation of buffy coat platelet component production: comparison to platelet‐rich plasma platelet production | |
Hechler et al. | Preserved functional and biochemical characteristics of platelet components prepared with amotosalen and ultraviolet A for pathogen inactivation | |
Johnson et al. | Characterization of biologic response modifiers in the supernatant of conventional, refrigerated, and cryopreserved platelets | |
Tissot et al. | The storage lesions: from past to future | |
Raval et al. | The use of the mechanical fragility test in evaluating sublethal RBC injury during storage | |
Cancelas et al. | Stored red blood cell viability is maintained after treatment with a second‐generation S‐303 pathogen inactivation process | |
Fuchs et al. | Neutrophils release extracellular DNA traps during storage of red blood cell units | |
Backholer et al. | A paired comparison of thawed and liquid plasma | |
Slichter et al. | Platelets stored in whole blood at 4° C: in vivo posttransfusion platelet recoveries and survivals and in vitro hemostatic function | |
Kriebardis et al. | Microparticles variability in fresh frozen plasma: preparation protocol and storage time effects | |
Johnson et al. | Evaluation of the quality of blood components prepared using the Reveos automated blood processing system | |
Ostrowski et al. | Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology | |
Lelkens et al. | Prolonged post‐thaw shelf life of red cells frozen without prefreeze removal of excess glycerol | |
Chan et al. | Microparticle profile and procoagulant activity of fresh‐frozen plasma is affected by whole blood leukoreduction rather than 24‐hour room temperature hold | |
West et al. | Transfusion-related acute lung injury: advances in understanding the role of proinflammatory mediators in its genesis | |
Lagerberg et al. | Evaluation of the quality of blood components obtained after automated separation of whole blood by a new multiunit processor | |
Nogawa et al. | Parallel comparison of apheresis‐collected platelet concentrates stored in four different additive solutions | |
Cookson et al. | Thrombin generation and coagulation factor content of thawed plasma and platelet concentrates | |
Agey et al. | Effects of Intercept pathogen reduction treatment on extended cold storage of apheresis platelets |